DENVER--(BUSINESS WIRE)--July 20, 2006--Corgenix Medical Corporation (OTC BB: CONX - News), a worldwide developer and marketer of diagnostic test kits, has submitted a Premarket Notification (510k) to the U.S. Food and Drug Administration (FDA) for the Company's AspirinWorks® Test Kit, the Company's newest diagnostic product for cardiovascular disease.
